| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.11 | 0.8 |